CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Telehealth ConsultationWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (3)


Name (Synonyms) Correlation
D006333 Heart Failure NIH 0.38
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (1)


Name (Synonyms) Correlation
HP:0001635 Congestive heart failure HPO 0.38

There is one clinical trial.

Clinical Trials


1 The California Home Abortion by Telehealth (CHAT) Study

This study aims to assess efficacy and safety outcomes of a model of abortion care implemented in response to the COVID-19 pandemic. The study involves telehealth for counseling and information, to maintain social distancing, but requires participants to pick up their medications in the clinic in keeping with the Food and Drug Administration's (FDA's) Risk Evaluation and Mitigation Strategy (REMS) requirements. The study will compare efficacy of this model to usual in-clinic care based on published rates. It will also investigate participant acceptability and feasibility of this model of care.

NCT04432792 Abortion Early Other: Telehealth Consultation

Primary Outcomes

Description: The proportion of participants who have a successful abortion defined as complete abortion without continuing pregnancy, need for manual vacuum aspiration or an additional round of treatment to complete the abortion.

Measure: The proportion of participants with a successful abortion

Time: Documented resolution of pregnancy, for most patients assessed at 7 days

Description: The proportion of participants reporting being satisfied or very satisfied with telehealth for abortion.

Measure: The proportion of participants reporting satisfaction with telehealth for abortion

Time: Documented satisfaction measured at approximately 4 weeks follow up

Description: The proportion of participants reporting they would use the telehealth option again if needed

Measure: The proportion of participants reporting they would use the telehealth option again if needed

Time: Documented at approximately 4 weeks follow up

Description: The total percentage of participants who carried out the study tasks as directed.

Measure: The total percentage of participants who carried out the study tasks as directed.

Time: Documented at the 7 day follow up survey

Secondary Outcomes

Description: Major adverse events, either reported by the patient or documented through clinical records. Major adverse events will be defined as any abortion requiring blood transfusion, surgery, or hospitalization

Measure: The total percentage of participants who experienced a major adverse event

Time: Assessed at the 7 day and 4 week follow up surveys or any unscheduled contacts from participants


No related HPO nodes (Using clinical trials)